德尔塔
您当前所在位置:首页 > 材料科学 > 光电化学
「同位素标记抑制剂」CAS:855997-63-6|2-Nitrobenzoic acid-d4

「同位素标记抑制剂」CAS:855997-63-6|2-Nitrobenzoic acid-d4

作者:德尔塔生物 日期:2025-06-13

生物活性:2-Nitrobenzoic acid-d4 is the deuterium labeled 2-Nitrobenzoic acid[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:171.14Formula:C7HD4NO4CAS 号:855997-63-6中文名称:苯甲酸 2,3,4,5-d4 酸,6-硝基-运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (523 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:2028292-29-5|α,β-Trehalose-d2

「同位素标记抑制剂」CAS:2028292-29-5|α,β-Trehalose-d2

作者:德尔塔生物 日期:2025-06-13

生物活性:α,β-Trehalose-d2 is the deuterium labeled α,β-Trehalose[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:344.31Formula:C12H20D2O11CAS 号:2028292-29-5中文名称:α,β-海藻糖-d2运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (522 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:70849-27-3|D-Altrose-1-13C

「同位素标记抑制剂」CAS:70849-27-3|D-Altrose-1-13C

作者:德尔塔生物 日期:2025-06-13

生物活性:D-Altrose-1-13C is the 13C labeled D(+)-Altrose[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:181.15Formula:C513CH12O6CAS 号:70849-27-3非标记 CAS:2595-97-3中文名称:D-阿卓糖-13C运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (518 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:83379-36-6|D-(+)-Talose-13C-1

「同位素标记抑制剂」CAS:83379-36-6|D-(+)-Talose-13C-1

作者:德尔塔生物 日期:2025-06-13

生物活性:D-(+)-Talose-13C-1 is the 13C labeled D-(+)-Talose[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:181.15Formula:C513CH12O6CAS 号:83379-36-6中文名称:D-(+)-塔罗糖-13C-1运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (519 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:70849-29-5|D-(+)-Talose-13C

「同位素标记抑制剂」CAS:70849-29-5|D-(+)-Talose-13C

作者:德尔塔生物 日期:2025-06-13

生物活性:D-(+)-Talose-13C is the 13C labeled 1-O-Acetyl-2,3,5-Tri-O-benzoyl-beta-D-Ribofuranose[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:181.15Formula:C513CH12O6CAS 号:70849-29-5非标记 CAS:2595-98-4中文名称:D-(+)-塔罗糖-13C运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (519 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:2747-89-9|DL-Lysine2-15N dihydrochloride

「同位素标记抑制剂」CAS:2747-89-9|DL-Lysine2-15N dihydrochloride

作者:德尔塔生物 日期:2025-06-13

生物活性:DL-Lysine2-15N (dihydrochloride) is the 15N labeled DL-Lysine2 dihydrochloride[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:220.10Formula:C6H16Cl2N15NO2CAS 号:2747-89-9中文名称:DL-赖氨酸-2-15N二盐酸盐运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (516 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1246523-63-6|1,3-Dimyristoyl-glycerol-d5

「同位素标记抑制剂」CAS:1246523-63-6|1,3-Dimyristoyl-glycerol-d5

作者:德尔塔生物 日期:2025-06-13

生物活性:1,3-Dimyristoyl-glycerol-d5 is deuterium labeled 1,3-Dimyristoyl-glycerol.体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:517.84Formula:C31H55D5O5CAS 号:1246523-63-6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (512 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]

「同位素标记抑制剂」CAS:1794941-80-2|Glycidyl Palmitate-d5

「同位素标记抑制剂」CAS:1794941-80-2|Glycidyl Palmitate-d5

作者:德尔塔生物 日期:2025-06-13

生物活性:Glycidyl Palmitate-d5 is the deuterium labeled Glycidyl Palmitate[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:317.52Formula:C19H31D5O3CAS 号:1794941-80-2非标记 CAS:7501-44-2运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (513 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1246818-85-8|(Rac)-1,2-Distearoyl-3-chloropropanediol-d5

「同位素标记抑制剂」CAS:1246818-85-8|(Rac)-1,2-Distearoyl-3-chloropropanediol-d5

作者:德尔塔生物 日期:2025-06-13

生物活性:rac-1,2-Distearoyl-3-chloropropanediol-d5 is a biochemical reagent that can be used as a biological material or organic compound for life science related research.分子量:648.49Formula:C39H70D5ClO4CAS 号:1246818-85-8非标记 CAS:72468-92-9运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (489 KB)产品使用指南 (1538 KB)

「同位素标记抑制剂」CAS:340257-58-1|N-Caproicacid-d11 sodium

「同位素标记抑制剂」CAS:340257-58-1|N-Caproicacid-d11 sodium

作者:德尔塔生物 日期:2025-06-13

生物活性:N-caproicacidsodiumsalt-d11 is the deuterium labeled N-caproicacidsodiumsalt[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:149.21Formula:C6D11NaO2CAS 号:340257-58-1中文名称:己酸 钠盐-d11运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (521 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1261393-28-5|Omeprazole sulfone-13C,d3

「同位素标记抑制剂」CAS:1261393-28-5|Omeprazole sulfone-13C,d3

作者:德尔塔生物 日期:2025-06-13

生物活性:Omeprazole metabolite Omeprazole sulfone-13C,d3 is the deuterium and 13C labeled Omeprazole metabolite Omeprazole sulfone[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Omeprazole sulfone-13C,d3 相关抗体:FMO3 Antibody (YA1992)分子量:365.43Formula:C1613CH16D3N3O4SCAS 号:1261393-28-5非标记 CAS:88546-55-8中文名称:奥美拉唑砜-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (521 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1504554-02-2|Iloperidone metabolite Hydroxy Iloperidone-d3

「同位素标记抑制剂」CAS:1504554-02-2|Iloperidone metabolite Hydroxy Iloperidone-d3

作者:德尔塔生物 日期:2025-06-13

生物活性:Iloperidone metabolite Hydroxy Iloperidone-d3 is the deuterium labeled Iloperidone metabolite Hydroxy Iloperidone[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Iloperidone metabolite Hydroxy Iloperidone-d3 相关抗体:FMO3 Antibody (YA1992)分子量:431.51Formula:C24H26D3FN2O4CAS 号:1504554-02-2非标记 CAS:133454-55-4中文名称:伊潘立酮代谢物P88杂质-d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (523 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:352534-95-3|PIPES-d18

「同位素标记抑制剂」CAS:352534-95-3|PIPES-d18

作者:德尔塔生物 日期:2025-06-13

生物活性:PIPES-d18 is the deuterium labeled PIPES[1]. PIPES (1,4-Piperazinediethanesulfonic acid) is an important component of PIPES buffer agent used in biochemistry[2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:320.48Formula:C8D18N2O6S2CAS 号:352534-95-3非标记 CAS:5625-37-6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (529 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief][2]. Jason Moggridge, et al. Sensitive Detection of Immunoglobulin G Stability Using in Real-Time Isothermal Differential Scanning Fluorimetry: Determinants of Protein Stability for Antibody-Based Therapeutics. Technol Cancer Res Treat. 2017 Dec;16(6):997-1005. [Content Brief]

「同位素标记抑制剂」CAS:1219804-15-5|3-(Cyclohexylamino)-1-propanesulfonic Acid-d17

「同位素标记抑制剂」CAS:1219804-15-5|3-(Cyclohexylamino)-1-propanesulfonic Acid-d17

作者:德尔塔生物 日期:2025-06-13

生物活性:3-(Cyclohexylamino)-1-propanesulfonic Acid-d17 is the deuterium labeled CAPS[1]. CAPS, cyclohexylaminopropane sulfonic acid, is a surfactant. CAPS can be used as biological buffer (0.05 M, pH 11) for dialysis[2][3].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:238.42Formula:C9H2D17NO3SCAS 号:1219804-15-5非标记 CAS:1135-40-6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (533 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief][2]. Bedard P R, et al. Ion Interaction: The Energetics and Mechanism of The Competitive Behavior Between Two Similarly Charged Molecules. 1. The Effect of Ionic Strength, Acetonitrile and Surfactant Concentration[J]. Journal of Liquid Chromatography, 1985, 8(13):2417-2443.[3]. Oberley TD, et al. The effect of the dimeric and multimeric forms of fibronectin on the adhesion and growth of primary glomerular cells. Exp Cell Res. 1983 May145(2):265-76. [Content Brief]

「同位素标记抑制剂」CAS:352534-96-4|Tricine-d8

「同位素标记抑制剂」CAS:352534-96-4|Tricine-d8

作者:德尔塔生物 日期:2025-06-13

生物活性:Tricine-d8 is the deuterium labeled Tricine[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:187.22Formula:C6H5D8NO5CAS 号:352534-96-4非标记 CAS:5704-04-1中文名称:三(羟甲基)甲基甘氨酸-d8运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (522 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]